Browse All

Current Filters

CLEAR FILTER x

TITLE

Prognostic Value of Baseline Serum Neurofilament Light Chain Levels in People with Relapsing Multiple Sclerosis by Prior Treatment Status and DMT Type

Author:Bittner, Stefan   H. Cross, Anne   Pardo, Gabriel   S. Zamvil, Scott   Bhatt, Alit   Wei, Wenjia   Boer, Ibolya   Thouvenot, Eric   Ziemssen, Tjalf   

Session Name:P5: Multiple Sclerosis: Biomarkers and Immunology 1  

Topic:Multiple Sclerosis  

Program Number:P5.009  

Author Institution:Department of Neurology, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany, Mainz, Germany  Oklahoma Medical Research Foundation, Oklahoma City, OK, USA, Oklahoma City, OK  Novartis Healthcare Pvt. Ltd., Hyderabad, India, Hyderabad, India  Department of Neurology, Centre Hospitalier Universitaire (CHU) Nîmes, University of Montpellier, Nîmes, France, Nimes Cedex 9, France  

NeofiLos –sNfL in Daily Clinical Routine

Author:Akgün, Katja   Katrin, Schuh   Schwab Sauerbeck, Inessa   Ziemssen, Tjalf   

Session Name:P5: Multiple Sclerosis: Biomarkers and Immunology 1  

Topic:Multiple Sclerosis  

Program Number:P5.015  

Author Institution:Center of Clinical Neuroscience, Dresden, Germany  Novartis Pharma GmbH, Nuernberg, Germany  

Hidden Problems in Multiple Sclerosis: Gaps Between Patient Experience and Outcome Assessments

Author:Lysandropoulos, Andreas   Suminski, Naomi   Ziemssen, Tjalf   

Session Name:P7: Multiple Sclerosis: Patient Experience and Patient-reported Outcomes in Multiple Sclerosis and Related Diseases  

Topic:Multiple Sclerosis  

Program Number:P7.003  

Author Institution:Parexel, Billerica, MA  University Clinic Dresden, Dresden, Germany  

Longer-term (up to 6 Years) Efficacy and Safety of Ofatumumab in People with Non-highly Active MS Early in the Disease Course

Author:Ziemssen, Tjalf   Schuh, Katrin   Hentschke, Christian   Nelles, Gereon   

Session Name:P11: Multiple Sclerosis: Clinical and Translational Research in MS 1  

Topic:Multiple Sclerosis  

Program Number:P11.003  

Author Institution:University Clinic Carl-Gustav Carus, Dresden, Germany  Novartis Pharma GmbH, Nuremberg, Germany  Neuromed-Campus, Cologne, Germany